Springboard
Platinum Building, St. John's Innovation Park, Cowley Road, Cambridge, Cambridgeshire, CB4 0WS, United Kingdom
Overview
Springboard has evolved into a full time 13 week bootcamp accelerator programme based in ideaSpace within the Cambridge University. This new format has been funded by a syndicate of angel investors that includes NESTA and will be managed by Jon Bradford, the founder of The Difference Engine. Springboard will adopt a model comparable to Y Combinator and TechStars. It will provide £5,000 per founder (to a maximum of three founders) for 6% of the business with intensive mentoring and support throughout the bootcamp from over 50 accomplished mentors including experienced entrepreneurs and venture capitalists. The programme ends with the teams presenting their business to venture capitalists and angel investors at an Investor Day. As of February 2013, Springboard has joined forces with TechStars and became [TechStars London](http://techcrunch.com/2013/02/20/u-s-accelerator-techstars-goes-global-merges-with-uks-springboard-and-opens-its-first-international-outpost-in-london-something-feels-different-now-says-cohen/).
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 2
Sector focus
- Education
- Finance
- Internet
Investment portfolio
- Andel
Participated · Equity · Oct 2025
Andel is building a cooperative pharmacy-benefit platform that pools the buying power of employer members to buy GLP-1 weight-loss medications and other costly branded drugs directly from manufacturers at below-market rates. Employers choose a subsidy level, and Andel handles prescription verification, payment, and next-day delivery through its native applications and wholly owned Andel Pharmacy, LLC. By bypassing traditional pharmacy-benefit managers, the model aims to lower costs for employers while giving employees immediate access to brand-name medicines without prior-authorization hurdles. Co-founders Jay Bregman—whose prior ventures include Hailo and Thimble—and pharmacist Ritu Malhotra, PharmD, combine startup and healthcare-benefits expertise to navigate the complex drug-pricing ecosystem. The company announced plans to launch nationwide in early 2026. Andel has raised $4.5 million to fund this rollout, but it has not yet disclosed revenue, user, or prescription-volume metrics.